{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:25:28Z","timestamp":1778754328113,"version":"3.51.4"},"publisher-location":"Cham","reference-count":38,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031803956","type":"print"},{"value":"9783031803963","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-80396-3_9","type":"book-chapter","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:00:06Z","timestamp":1742356806000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary Hyperparathyroidism in MEN2 Syndromes"],"prefix":"10.1007","author":[{"given":"Katerina","family":"Saltiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Alevizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"Suppl 1","key":"9_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1756-6614-6-S1-S10","volume":"6","author":"M Alevizaki","year":"2013","unstructured":"Alevizaki M (2013) Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe. Thyroid Res 6(Suppl 1):S10","journal-title":"Thyroid Res"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","volume":"257","author":"T Carling","year":"2005","unstructured":"Carling T, Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27\u201337","journal-title":"J Intern Med"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.14310\/horm.2002.1343","volume":"11","author":"S Dimas","year":"2012","unstructured":"Dimas S, Michas S, Christakis I, Augoustis C, Alevizaki M (2012) Minimally invasive parathyroidectomy in patients with previous neck surgery. Hormones (Athens) 11:160\u2013165","journal-title":"Hormones (Athens)"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/110241501750099294","volume":"167","author":"C Dotzenrath","year":"2001","unstructured":"Dotzenrath C, Cupisti K, Goretzki PE, Yang Q, Simon D, Ohmann C, Roher HD (2001) Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg 167:173\u2013178","journal-title":"Eur J Surg"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1210\/jc.2011-2046","volume":"97","author":"R Elisei","year":"2012","unstructured":"Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, Agate L, Cappagli V, Miccoli P, Berti P, Faviana P, Ugolini C, Basolo F, Vitti P, Pinchera A (2012) The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab 97:426\u2013435","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000346174","volume":"1","author":"R Elisei","year":"2013","unstructured":"Elisei R, Alevizaki M, Conte-Devolx B, Frank-Raue K, Leite V, Williams GR (2013) 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J 1:216\u2013231","journal-title":"Eur Thyroid J"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hufner M, Wohllk N, Opocher G, Dvorakova S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorlander C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wuster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32:51\u201358","journal-title":"Hum Mutat"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0039-6060(96)80042-0","volume":"120","author":"KK Herfarth","year":"1996","unstructured":"Herfarth KK, Bartsch D, Doherty GM, Wells SA Jr, Lairmore TC (1996) Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 120:966\u201373; discussion 973-4","journal-title":"Surgery"},{"issue":"7","key":"9_CR9","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/cancers15072125","volume":"15","author":"M Holm","year":"2023","unstructured":"Holm M, Vestergaard P, Poulsen MM, Rasmussen \u00c5K, Feldt-Rasmussen U, Bay M, Rolighed L, Londero S, Pedersen HB, Hahn CH, Rask KB, Nielsen HH, Gaustadnes M, Rossing MC, Hermann AP, Godballe C, Mathiesen JS (2023) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A in Denmark 1930\u20132021: a nationwide population-based retrospective study. Cancers (Basel) 15(7):2125. https:\/\/doi.org\/10.3390\/cancers15072125","journal-title":"Cancers (Basel)"},{"issue":"8","key":"9_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Carnaille B, Palazzo FF, Vriens M (2015) Hereditary hyperparathyroidism\u2014a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck\u2019s Arch Surg 400(8):867\u2013886. https:\/\/doi.org\/10.1007\/s00423-015-1342-7","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/endrev\/bnad009","volume":"44","author":"S Jha","year":"2023","unstructured":"Jha S, Simonds WF (2023) Molecular and clinical Spectrum of primary hyperparathyroidism. Endocr Rev 44:779\u2013818","journal-title":"Endocr Rev"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1530\/eje.0.1390410","volume":"139","author":"HJ Karga","year":"1998","unstructured":"Karga HJ, Karayianni MK, Linos DA, Tseleni SC, Karaiskos KD, Papapetrou PD (1998) Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma. Eur J Endocrinol 139:410\u2013415","journal-title":"Eur J Endocrinol"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565\u2013612","journal-title":"Thyroid"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s002689900123","volume":"20","author":"JL Kraimps","year":"1996","unstructured":"Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F, Sarfati E, Dupond JL, Maes B, Travagli JP, Boneu A, Roger P, Houdent C, Barbier J, Modigliani E (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d\u2019Etude des Tumeurs a Calcitonine (GETC, French calcitonin Tumors study group), French Association of Endocrine Surgeons. World J Surg 20:808\u2013812. discussion 812-3","journal-title":"World J Surg"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/EC-20-0163","volume":"9","author":"LV Larsen","year":"2020","unstructured":"Larsen LV, Mirebeau-Prunier D, Imai T, Alvarez-Escola C, Hasse-Lazar K, Censi S, Castroneves LA, Sakurai A, Kihara M, Horiuchi K, Barbu VD, Borson-Chazot F, Gimenez-Roqueplo AP, Pigny P, Pinson S, Wohllk N, Eng C, Aydogan BI, Saranath D, Dvorakova S, Castinetti F, Patocs A, Bergant D, Links TP, Peczkowska M, Hoff AO, Mian C, Dwight T, Jarzab B, Neumann HPH, Robledo M, Uchino S, Barlier A, Godballe C, Mathiesen JS (2020) Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study. Endocr Connect 9:489\u2013497","journal-title":"Endocr Connect"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1210\/jc.2012-3192","volume":"98","author":"A Machens","year":"2013","unstructured":"Machens A, Lorenz K, Dralle H (2013a) Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J Clin Endocrinol Metab 98:E336\u2013E345","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/EJE-12-0919","volume":"168","author":"A Machens","year":"2013","unstructured":"Machens A, Lorenz K, Sekulla C, H\u00f6ppner W, Frank-Raue K, Raue F, Dralle H (2013b) Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. Eur J Endocrinol 168:307\u2013314","journal-title":"Eur J Endocrinol"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12020-020-02232-5","volume":"68","author":"A Machens","year":"2020","unstructured":"Machens A, Elwerr M, Lorenz K, Weber F, Dralle H (2020) 100-year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A. Endocrine 68:368\u2013376","journal-title":"Endocrine"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10689-021-00282-w","volume":"21","author":"A Machens","year":"2022","unstructured":"Machens A, Lorenz K, Weber F, Dralle H (2022) Medullary thyroid cancer and pheochromocytoma in MEN2A: are there parent of origin effects on disease expression? Fam Cancer 21:473\u2013478","journal-title":"Fam Cancer"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"e734","DOI":"10.1210\/clinem\/dgad156","volume":"108","author":"A Machens","year":"2023","unstructured":"Machens A, Lorenz K, Brandenburg T, F\u00fchrer-Sakel D, Weber F, Dralle H (2023) The changing face of multiple endocrine neoplasia 2A: from symptom-based to preventative medicine. J Clin Endocrinol Metab 108:e734\u2013e742","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/thy.2010.0336","volume":"21","author":"PK Magalhaes","year":"2011","unstructured":"Magalhaes PK, Antonini SR, de Paula FJ, de Freitas LC, Maciel LM (2011) Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2A in a 5-year-old child. Thyroid 21:547\u2013550","journal-title":"Thyroid"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1210\/jc.2008-2640","volume":"94","author":"C Marcocci","year":"2009","unstructured":"Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, Peacock M (2009) Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. J Clin Endocrinol Metab 94:2766\u20132772","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10689-009-9250-z","volume":"8","author":"C Mian","year":"2009","unstructured":"Mian C, Barollo S, Zambonin L, Pennelli G, Bernante P, Pelizzo MR, Nacamulli D, Mantero F, Girelli ME, Opocher G (2009) Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation. Fam Cancer 8:379\u2013382","journal-title":"Fam Cancer"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/SLA.0000000000001464","volume":"262","author":"JF Moley","year":"2015","unstructured":"Moley JF, Skinner M, Gillanders WE, Lairmore TC, Rowland KJ, Traugott AL, Jin LX, Wells SA Jr (2015) Management of the parathyroid glands during preventive thyroidectomy in patients with multiple endocrine neoplasia type 2. Ann Surg 262:641\u2013646","journal-title":"Ann Surg"},{"key":"9_CR25","first-page":"1031","volume":"114","author":"DS O\u2019Riordain","year":"1993","unstructured":"O\u2019Riordain DS, O\u2019Brien T, Grant CS, Weaver A, Gharib H, van Heerden JA (1993) Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery 114:1031\u20137; discussion 1037-9","journal-title":"Surgery"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14310\/horm.2002.1218","volume":"8","author":"F Raue","year":"2009","unstructured":"Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens) 8:23\u201328","journal-title":"Hormones (Athens)"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1210\/js.2018-00178","volume":"2","author":"F Raue","year":"2018","unstructured":"Raue F, Frank-Raue K (2018) Update on multiple endocrine neoplasia type 2: focus on medullary thyroid carcinoma. J Endocr Soc 2:933\u2013943","journal-title":"J Endocr Soc"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","volume":"238","author":"F Raue","year":"1995","unstructured":"Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, Frilling A, Limbert E, Llenas LF, Niederle B (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238:369\u2013373","journal-title":"J Intern Med"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2265.2010.03900.x","volume":"74","author":"C Romei","year":"2011","unstructured":"Romei C, Cosci B, Renzini G, Bottici V, Molinaro E, Agate L, Passannanti P, Viola D, Biagini A, Basolo F, Ugolini C, Materazzi G, Pinchera A, Vitti P, Elisei R (2011) RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clin Endocrinol 74:241\u2013247","journal-title":"Clin Endocrinol"},{"issue":"4","key":"9_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1530\/EJE-14-0817","volume":"172","author":"HL Sarika","year":"2015","unstructured":"Sarika HL, Papathoma A, Garofalaki M, Saltiki K, Pappa T, Pazaitou-Panayiotou K, Anastasiou E, Alevizaki M (2015) Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades. Eur J Endocrinol 172(4):501\u2013509. https:\/\/doi.org\/10.1530\/EJE-14-0817","journal-title":"Eur J Endocrinol"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4158\/EP10050.OR","volume":"17","author":"A Scholten","year":"2011","unstructured":"Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel Rinkes IH (2011) Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract 17:7\u201315","journal-title":"Endocr Pract"},{"key":"9_CR32","first-page":"487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L, Chabre O, Boneu A, Caron J, Houdent C, Modigliani E, Rohmer V, Schlumberger M, Eng C, Guillausseau PJ, Lenoir GM (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83:487\u2013491","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","volume":"47","author":"AL Steiner","year":"1968","unstructured":"Steiner AL, Goodman AD, Powers SR (1968) Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing\u2019s disease: multiple endocrine neoplasia, type 2. Medicine (Baltimore) 47:371\u2013409","journal-title":"Medicine (Baltimore)"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1750-1172-8-50","volume":"8","author":"BA Twigt","year":"2013","unstructured":"Twigt BA, Scholten A, Valk GD, Rinkes IH, Vriens MR (2013) Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up. Orphanet J Rare Dis 8:50","journal-title":"Orphanet J Rare Dis"},{"key":"9_CR35","first-page":"362","volume":"113","author":"S Uchino","year":"2012","unstructured":"Uchino S (2012) Multiple endocrine neoplasia type 2 in Japan: large-scale analysis of data from the MEN consortium of Japan. Nihon Geka Gakkai Zasshi 113:362\u2013367","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-14-0818","volume":"172","author":"N Vald\u00e9s","year":"2015","unstructured":"Vald\u00e9s N, Navarro E, Mesa J, Caster\u00e1s A, Alc\u00e1zar V, Lamas C, T\u00e9bar J, Casta\u00f1o L, Gaztambide S, Forga L (2015) RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation. Eur J Endocrinol 172:301\u2013307","journal-title":"Eur J Endocrinol"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567\u2013610","journal-title":"Thyroid"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1507\/endocrj.K09E-005","volume":"56","author":"S Yoshida","year":"2009","unstructured":"Yoshida S, Imai T, Kikumori T, Wada M, Sawaki M, Takada H, Yamada T, Sato S, Sassa M, Uchida H, Watanabe R, Kagawa C, Nakao A, Kiuchi T (2009) Long term parathyroid function following total parathyroidectomy with autotransplantation in adult patients with MEN2A. Endocr J 56:545\u2013551","journal-title":"Endocr J"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-80396-3_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:00:09Z","timestamp":1742356809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-80396-3_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031803956","9783031803963"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-80396-3_9","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"20 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}